Assignee
ONCIMMUNE GERMANY GMBH
DE·2 granted patents·3 pending applications·0 citations·filing 2018–2020
Top patents by PatentIndex Score
5 records- 0161US11609237B2Marker sequences for diagnosing and stratifying systemic sclerosis patientsONCIMMUNE GERMANY GMBH·Filed 2019·Granted Mar 21, 2023·0 cites·11 claims
- 0255US11860162B2Marker sequences for diagnosing and stratifying SLE patientsONCIMMUNE GERMANY GMBH·Filed 2020·Granted Jan 2, 2024·0 cites·9 claims
- 0340US2022317125A1Melanoma biomarkersONCIMMUNE GERMANY GMBH·Filed 2020·Application pending·0 cites
- 0437US2021231663A1Melanoma checkpoint inhibitor detection and treatmentONCIMMUNE GERMANY GMBH·Filed 2018·Application pending·0 cites
- 0536US2020150117A1Immuno-oncology for the treatment of cancerONCIMMUNE GERMANY GMBH·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONCIMMUNE GERMANY GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →